TAHITI couples CRISPR with transposable elements from plants to edit cash crops such as corn and soybean with reduced ...

Imprint has raised $15 million to decode the body's immune memory for understanding chronic diseases, such as long-COVID and ...

Treated with an individualized gene-editing therapy that corrects mutations directly on the genome, a patient shows improvement from a rare metabolic disease.

Some of the most widely used methods include a tangential flow filter (TFF). Instead of flowing through a filter, a sample ...

Not designing with manufacturing in mind—even during early development—is a key reason fledgling biopharma companies fail.

Current setbacks cannot prevent gene-editing companies from advancing closer to “one-and-done” cures and new products.

Study in mice shows how a host-elicited factor benefits gut immunological homeostasis by selectively targeting commensal ceramide molecules.

Forge says it will provide Fractyl process development, cGMP manufacturing, and analytical development services.

Ring Therapeutics says it has demonstrated the ability to encapsidate nucleic acid payloads through in vitro assembly.

Innovative delivery techniques, including high-tech nanoparticles and electroporationdevices, may convey more gene therapies into the clinic.

Controlling the entire cell therapy production process—from material receipt to product release—is “essential,” according to AstraZeneca, which says its new $300 million manufacturing facility will be ...

Although not designed to eliminate experiments, the model, which is intended to accelerate process development, can reduce the number needed.